Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to -$291.3 million.

  • CorMedix's Cash from Investing Activities fell 470850.1% to -$291.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$312.0 million, marking a year-over-year decrease of 465648.45%. This contributed to the annual value of $21.2 million for FY2024, which is 22443.5% up from last year.
  • Per CorMedix's latest filing, its Cash from Investing Activities stood at -$291.3 million for Q3 2025, which was down 470850.1% from -$20.2 million recorded in Q2 2025.
  • CorMedix's Cash from Investing Activities' 5-year high stood at $8.9 million during Q1 2024, with a 5-year trough of -$291.3 million in Q3 2025.
  • For the 5-year period, CorMedix's Cash from Investing Activities averaged around -$19.9 million, with its median value being -$256218.0 (2021).
  • As far as peak fluctuations go, CorMedix's Cash from Investing Activities soared by 38541.16% in 2022, and later tumbled by 470850.1% in 2025.
  • CorMedix's Cash from Investing Activities (Quarter) stood at -$7.1 million in 2021, then surged by 99.97% to -$1861.0 in 2022, then plummeted by 789088.88% to -$14.7 million in 2023, then surged by 97.93% to -$304161.0 in 2024, then plummeted by 95678.37% to -$291.3 million in 2025.
  • Its Cash from Investing Activities stands at -$291.3 million for Q3 2025, versus -$20.2 million for Q2 2025 and -$194820.0 for Q1 2025.